The evolving role of tiotropium in asthma

References

• Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention2017 Available from http://ginasthma.org/Accessed July 24, 2017
   Google Scholar
• MasoliMFabianDHoltSBeasleyRGlobal Initiative for Asthma (GINA) ProgramThe global burden of asthma: executive summary of the GINA dissemination committee reportAllergy200459546947815080825
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAsthma. fact sheet no. 307 Available from: http://www.who.int/mediacentre/factsheets/fs307/en/. Updated 2013Accessed December 14, 2016
   Google Scholar
• PriceDMathiesonNMulgirigamaAP17 the burden of ICS/LABA-treated asthma patients in the UK adult populationThorax201368Suppl 3A82
   PubMed Web of Science ®Google Scholar
• ChangABosseYTargeting single molecules in asthma benefits fewTrends Mol Med2016221193594527692867
   PubMed Web of Science ®Google Scholar
• CanningBJReflex regulation of airway smooth muscle toneJ Appl Physiol (1985)2006101397198516728519
   PubMed Web of Science ®Google Scholar
• GoyalMJasejaHVermaNIncreased parasympathetic tone as the underlying cause of asthma: a hypothesisMed Hypotheses201074466166420044211
   PubMed Web of Science ®Google Scholar
• BarnesPJThe pharmacological properties of tiotropiumChest2000117Suppl 263S66S10673478
   PubMed Web of Science ®Google Scholar
• NovelliFMalagrinoLDenteFLPaggiaroPEfficacy of anticholinergic drugs in asthmaExpert Rev Respir Med20126330931922788945
   PubMed Web of Science ®Google Scholar
• BusseWWDahlRJenkinsCCruzAALong-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?Eur Respir Rev201625139546426929422
   PubMed Web of Science ®Google Scholar
• DahlREngelMDusserDSafety and tolerability of once-daily tiotropium respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: a pooled safety analysisRespir Med201611810211127578478
   PubMed Web of Science ®Google Scholar
• KerstjensHAEngelMDahlRTiotropium in asthma poorly controlled with standard combination therapyN Engl J Med2012367131198120722938706
   PubMed Web of Science ®Google Scholar
• KerstjensHAMoroni-ZentgrafPBronchodilator reversibility and cardiac considerations with use of tiotropiumLancet Respir Med201538e25e2626282477
   PubMed Web of Science ®Google Scholar
• PaggiaroPHalpinDMBuhlRThe effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trialJ Allergy Clin Immunol Pract20164110411326563670
   PubMed Web of Science ®Google Scholar
• AndersonDEKewKMBoyterACLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthmaCochrane Database Syst Rev20158CD01139726301488
   PubMedGoogle Scholar
• KewKMDahriKLong-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthmaCochrane Database Syst Rev20161CD01172126798035
   PubMed Web of Science ®Google Scholar
• KewKMEvansDJAllisonDEBoyterACLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthmaCochrane Database Syst Rev20156CD01143826031392
   PubMed Web of Science ®Google Scholar
• RodrigoGJCastro-RodriguezJAWhat is the role of tiotropium in asthma?: a systematic review with meta-analysisChest2015147238839625322075
   PubMed Web of Science ®Google Scholar
• VogelbergCMoroni-ZentgrafPLeonaviciute-KlimantavicieneMA randomised dose-ranging study of tiotropium respimat® in children with symptomatic asthma despite inhaled corticosteroidsRespir Res2015162025851298
   PubMed Web of Science ®Google Scholar
• VogelbergCEngelMMoroni-ZentgrafPTiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging studyRespir Med201410891268127625081651
   PubMed Web of Science ®Google Scholar
• SchmidtOHamelmannEVogelbergCOnce-daily tiotropium respimat® add-on therapy improves lung function in children with moderate symptomatic asthmaEur Respir J201648A4398
   Web of Science ®Google Scholar
• BisgaardHVandewalkerMGrahamLMMoroni-ZentgrafPEngelMEl AzziGSafety of tiotropium in pre-school children with symptomatic persistent asthmaEur Respir J201648A315
   Web of Science ®Google Scholar
• SzeflerSJMurphyKHarperTA phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthmaJ Allergy Clin Immunol Epub201729
   Web of Science ®Google Scholar
• HamelmannEBernsteinJAVandewalkerMA randomised controlled trial of tiotropium in adolescents with severe symptomatic asthmaEur Respir J2017491160110027811070
   PubMed Web of Science ®Google Scholar
• HamelmannEBatemanEDVogelbergCTiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trialJ Allergy Clin Immunol2016138244145026960245
   PubMed Web of Science ®Google Scholar
• SlaterMGPavordIDShawDEStep 4: stick or twist? a review of asthma therapyBMJ Open Respir Res201631e000143
   Google Scholar
• O’NeillSSweeneyJPattersonCCThe cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society difficult asthma registryThorax201570437637824917087
   PubMed Web of Science ®Google Scholar
• WillsonJBatemanEDPavordILloydAKrivasiTEsserDCost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting beta-agonistsAppl Health Econ Health Policy201412444745924974107
   PubMedGoogle Scholar
• HalpinDMTiotropium in asthma: what is the evidence and how does it fit in?World Allergy Organ J2016912927679681
   PubMed Web of Science ®Google Scholar
• ElersJStrandbygaardUPedersenLBackerVDaily use of salmeterol causes tolerance to bronchodilation with terbutaline in asthmatic subjectsOpen Respir Med J20104485020556208
   PubMedGoogle Scholar
• TanKSGroveAMcLeanAGnosspeliusYHallIPLipworthBJSystemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patientsAm J Respir Crit Care Med1997156128359230722
   PubMed Web of Science ®Google Scholar
• YatesDHSussmanHSShawMJBarnesPJChungKFRegular formoterol treatment in mild asthma. effect on bronchial responsiveness during and after treatmentAm J Respir Crit Care Med19951524 Pt 1117011747551366
   PubMed Web of Science ®Google Scholar
• KerstjensHAMoroni-ZentgrafPTashkinDPTiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic statusRespir Med201611719820627492532
   PubMed Web of Science ®Google Scholar
• BickmannDKaminWSharmaAWachtelHMoroni-ZentgrafPZielenSIn vitro determination of respimat® dose delivery in children: an evaluation based on inhalation flow profiles and mouth-throat modelsJ Aerosol Med Pulm Drug Deliv20162917685
   Web of Science ®Google Scholar
• KaminWFrankMKattenbeckSMoroni-ZentgrafPWachtelHZielenSA handling study to assess use of the respimat® soft mist™ inhaler in children under 5 years oldJ Aerosol Med Pulm Drug Deliv201528537238125844687
   PubMed Web of Science ®Google Scholar
• WachtelHBickmannDBreitkreutzJLangguthPCan pediatric throat models and air flow profiles improve our dose finding strategy?Respiratory Drug Delivery20101195204
   Google Scholar
• KerstjensHAEngelMDahlRTiotropium in asthma poorly controlled with standard combination therapyN Engl J Med20123671198120722938706
   PubMed Web of Science ®Google Scholar
• KerstjensHACasaleTBBleeckerERTiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trialsLancet Respir Med2015336737625682232
   PubMed Web of Science ®Google Scholar
• PaggiaroPHalpinDMBuhlRThe effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trialJ Allergy Clin Immunol Pract2016410411326563670
   PubMed Web of Science ®Google Scholar
• OhtaKIchinoseMTohdaYLong-term once-daily tiotropium respimat® is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled studyPLoS One201510e012410925894430
   PubMed Web of Science ®Google Scholar
• HamelmannEBatemanEDVogelbergCTiotropium add-on therapy in adolescents with moderate asthma: a 1-year randomized controlled trialJ Allergy Clin Immunol201613844145026960245
   PubMed Web of Science ®Google Scholar
• HamelmannEBernsteinJAVandewalkerMA randomised controlled trial of tiotropium in adolescents with severe symptomatic asthmaEur Respir J201749160110027811070
   PubMed Web of Science ®Google Scholar
• SchmidtOHamelmannEVogelbergCOnce-daily tiotropium Respimat® add-on therapy improves lung function in children with moderate symptomatic asthmaEur Respir J201648A4398
   Web of Science ®Google Scholar
• SzeflerSJMurphyKHarperT3rdA phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthmaJ Allergy Clin Immunol2017
   Web of Science ®Google Scholar
• BisgaardHVandewalkerMGrahamLMMoroni-ZentgrafPEngelMEl AzziGSafety of tiotropium in pre-school children with symptomatic persistent asthmaEur Respir J201648A315
   Web of Science ®Google Scholar